ARTICULATE BIOSCIENCES IS DEVELOPING
Injectable gels for treating arthritis and other soft tissue diseases
Biocompatible, cushioning, & lubricating
Tissue-protecting and function-restoring biomedical polymers
Our first product candidate will relieve pain and restore mobility to sufferers of osteoarthritis.
Spun out of Boston University in 2016, Articulate Biosciences is a preclinical stage medical device company. We are seeking rapid growth to expand our team and develop a portfolio of products for several key indications in orthopedics and soft tissue repair.
Using our patented ABX platform technology, our mission is to deliver long-lasting pain relief and restoration of mobility to sufferers of osteoarthritis. Through deep understanding of patient and clinician needs, combined with innovative breakthroughs in medical device technology, Articulate Biosciences strives to bring back quality of life by eliminating chronic joint pain
UNITED STATES PATENT COVERING ABX TECHNOLOGY IS ISSUED
PARTICIPANT IN THE NSF I-CORPS PROGRAM
WINNER IN THE MA MEDICAL DEVICE DEVELOPMENT CENTER (M2D2) $100K CHALLENGE
PARTICIPANT IN THE BOSTON UNIVERSITY QUESTROM SCHOOL OF BUSINESS SUMMER ACCELERATOR
ARTICULATE BIOSCIENCES IS FOUNDED